Tammy Utset to Muromonab-CD3
This is a "connection" page, showing publications Tammy Utset has written about Muromonab-CD3.
Connection Strength
0.219
-
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol. 2002 Sep; 29(9):1907-13.
Score: 0.219
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.